Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Chemical & Pharmaceuticals
- Environmental
- Health and Safety
- Water and Wastewater
- Food and Beverage
- Energy
- Oil, Gas & Refineries
- Agriculture
- Air and Climate
- Manufacturing, Other
- Mining
- Aerospace & Air Transport
- Logistics
- Pulp & Paper
- Waste and Recycling
- Soil and Groundwater
- Government
- Publishing / Media / Marketing
Oncology Suppliers Serving Myanmar
334 companies found
based inNew Taipei City, TAIWAN
Blue-Ray Biotech aims to provide global biotechnology researchers with innovative and reliable products to further accelerate the development of biotechnology. We have devoted ourselves to developing, manufacturing, and marketing cutting-edge ...
based inSeoul, SOUTH KOREA
We make software that transforms medical data into deeper insight. Our AI technology takes medical intelligence to the next level: data-driven medicine. We aim to solve the most critical issues in cancer care today: reduce medical cost and prolong ...
Predicting immunotherapy outcome with AI analysis; Finding more responders to cancer treatment; Tissue Data is huge and complex; Complex is what AI does ...
based inMalmö, SWEDEN
Ascelia Pharma is a biotech company focused on orphan oncology treatments. We develop and commercialize novel drugs that address unmet medical needs and have a clear development and market pathway. Oncoral is a novel oral irinotecan tablet in ...
based inNew Taipei City, TAIWAN
Established 2011 in Taiwan's aspiring capital Taipei, Zinexts Life Science has become a leading Biotechnology Company that is designing, developing and manufacturing a wide array of reliable, user friendly and cost effective Molecular Biology ...
based inValencia, SPAIN
Quibim, with headquarters in Valencia, Spain, is a global leader in whole-body medical imaging analysis. Quibim products are used worldwide by leading research teams. Partners use Quibim Precision®, a whole-body imaging ecosystem, for a wide range ...
based inFrederick, MARYLAND (USA)
In 2019, ProMedDx and GLAS Bio were acquired by Precision for Medicine, part of Precision Medicine Group. This new combination significantly bolstered the selection, scientific prowess and solutions available to customers from a single partner. With ...
Experienced global network of principal investigators, labs, and logistics experts available to source tissues for your research program. ...
based inHod Hasharon, ISRAEL
Virtual Ports designs and manufactures the only specialized retraction devices capable of using 5mm existing ports to retract organs entirely from within the body cavity to help surgeons overcome this challenge and to achieve a higher level of ...
The EndoGrab™ port-free endocavity retractor showcases Virtual Ports’ proprietary MicroAnchoring™ technology. It is the only device specifically designed and engineered to use an existing 5mm port to retract organs entirely from ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
Mechanism: BCL2/xL; Area under investigation: haematological malignancies; Date commenced phase: Q4 2019; Estimated Filing Acceptance: US: EU: Japan: China; Additional information: Partnered product. Molecule size: Small molecule; Status ...
based inBuffalo, NEW YORK (USA)
KSL Biomedical companies specialize in translational medicine impacting immunology, Oncology and Genomics. KSL can provide a full suite of regulatory, quality, clinical consulting and contract research organization ...
based inSarıyer, TURKEY
Virasoft Inc. was founded in 2015 with the support of the Turkish Ministry of Industry and Technology. We develop institution-specific projects in 4 main areas that meet all the needs of an institution in digital pathology. We focus on four main ...
The HER2 gene is an oncogene encoding the “Epidermal Growth Factor Receptor 2” which is a transmembrane glycoprotein. Amplification of the HER2 gene and overexpression of HER2 receptor on the cell membrane is observed in approximately ...
based inVancouver, BRITISH COLUMBIA (CANADA)
Zymeworks Inc. is a publicly listed (NYSE: ZYME), clinical-stage, biopharmaceutical company dedicated to the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially focused on the treatment of ...
based inMechelen, BELGIUM
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the ...
The fully automated Idylla EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge using only 1 FFPE tissue section from metastatic NSCLC showing a high concordance of >95% compared with reference ...
based inStockholm, SWEDEN
RaySearch® is advancing cancer treatment through pioneering software. Software has unlimited potential, and it is now the driving force for innovation in oncology. Medical science never stands still and neither does RaySearch. We work in close ...
Iterative parameter tuning and multiple re-optimization is no longer necessary with multi-criteria optimization in RayStation. This module allows for the continuous exploration of the possible treatment options in real time so you can find ...
based inSt. Paul, MINNESOTA (USA)
Since 1996, we have been dedicated to creating medical devices that help physicians do better work and allow patients to live better lives. We don’t just design and manufacture devices, we seek deep understanding of the clinical landscapes in which ...
Delivering custom RF technologies, quickly and reliably. Our RF-specific processes incorporate time-tested learnings and best practices to solve the toughest problems from design through manufacturing, without compromising customization or ...
based inNess Ziona, ISRAEL
BiomX is developing both natural and engineered phage cocktails designed to target and destroy bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as cystic fibrosis, inflammatory bowel disease, atopic ...
BiomX develops phage cocktails (or combinations) that target and kill specific pathogenic bacteria. Our phage cocktails, which are optimized through algorithms and experimental validation (in-vitro and in-vivo), contain multiple natural and/or ...
based inLaval, QUEBEC (CANADA)
Maranda Lauzon is a family owned and operated business, specializing in the distribution of products and services in the medical imaging industry for more than 35 years. Throughout the years, we have built a solid reputation for the diversity of our ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
DEP® irinotecan is an improved version of irinotecan (Camptosar®), predominantly used for colorectal cancer. DEP® irinotecan is a novel, patented nanoparticle formulation of SN-38, the active metabolite of irinotecan, delivered using ...
based inAlpharetta, GEORGIA (US) (USA)
Founded by Fred L. Aycock in 1992, Remington Medical Inc. specializes in medical devices. The maintenance, time, and money put into cleaning and sterilizing medical devices led us to develop some of the first disposable cables, some still in use ...
based inBoldon Colliery, UNITED KINGDOM
Immunodiagnostic Systems Holdings Ltd (hereafter referred to as IDS) is a leading in vitro diagnostic solution provider to the clinical laboratory market. We develop, manufacture and market innovative immunoassays and automated immunoanalyser ...
LISA-TRACKER Duo Infliximab is an enzyme linked immunoassay (ELISA) for the quantitative determination of Infliximab (anti-TNFα) and anti-Infliximab antibodies in human serum ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
